Cannabis Research in Tourette Syndrome

Monday 14 January 2019

“An Israeli study showed that of the patients without syndrome who tolerated cannabis treatment, many experienced a reduction in tic severity, better sleep and improved mood.”
-     Dr. David Hepburn

Abstract:

Patients with Gilles de la Tourette syndrome (GTS) experience reduced function and impaired quality of life. The current medical treatments for this syndrome can cause significant side effects and offer partial symptomatic relief.

In a few small trials medical cannabis (MC) has been suggested to offer symptomatic relief with a relatively benign side effect profile. We conducted a real-life assessment of clinical benefit and adverse effects of chronic MC treatment among patients with GTS.

Forty-Two GTS patients (33 males, mean age 34.5) were interviewed for this study. The total global impression score of efficacy was 3.85 out of a total of 5 possible points. Patients reported during the free discussion part of the interview about a reduction in tic severity, better sleep and improved mood as positive effects of MC.

Thirty-eight patients reported any kind of benefit from treatment while 10 patients with more than one year of consumption elected to stop treatment with MC for various reasons including severe side effects as psychosis in one patient.

Read the full article here:


Dr. Dave Hepburn website: https://doctordavidhepburn.com

0 comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...